The expression of LRRC8A is elevated in the tissues of colorectal cancer patients, which correlates with a shortened survival time, and the knockdown of LRRC8A in colon cancer cells inhibits tumorigenesis in a xenograft model (Zhang et al., 2018; Zhang et al., 2024). The gene discussed is LRRC8A; the disease is malignant colon neoplasm.